PT Metro Healthcare Indonesia Tbk has the GF Score of 79, which implies that the company
is
Likely to have average performance.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes PT Metro Healthcare Indonesia Tbk
is
Likely to have average performance.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
PT Metro Healthcare Indonesia Tbk GF Score Related Terms
ISX:CARE vs HCA, THC, DVA: GF Score Comparison
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk GF Score vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's GF Score distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's GF Score falls into.
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a GF Score of 79 as of Jul. 13, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. This is 65% above median its historical median of 48.00. Over the past decade, PT Metro Healthcare Indonesia Tbk's GF Score has ranged from 2.00 to 80.00.
Is PT Metro Healthcare Indonesia Tbk's GF Score too high?
PT Metro Healthcare Indonesia Tbk's current GF Score of 79 is 65% above median its 10-year median of 48.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 80.00. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's GF Score compare to HCA and THC?
PT Metro Healthcare Indonesia Tbk's GF Score of 79 can be compared against companies in the Healthcare Providers & Services industry. Historically, PT Metro Healthcare Indonesia Tbk's own GF Score has ranged from 2.00 to 80.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Healthcare Providers & Services company?
A good GF Score depends on the Healthcare Providers & Services industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. PT Metro Healthcare Indonesia Tbk's current GF Score is 79, which is 65% above median its own 10-year median of 48.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp368.01, compared to a current price of Rp426.00 — trading 15.8% above its estimated fair value. The current GF Score is 79, which is 65% above median its 10-year median of 48.00. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current GF Score is 79 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp426.00 is trading 15.8% above its estimated GF Value™ of Rp368.01.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
GF Score: 79 (65% above median its 10-year median of 48.00)
GF Value™: Rp368.01 vs. price of Rp426.00 (15.8% above fair value)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk Business Description
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
79GF Score
Get the complete analysis for ISX:CARE
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 